SCHEMBL9434141

SCHEMBL9434141

CC1=C(C#N)C(c2cccc([N+](=O)[O-])c2)C(c2cccnc2)=C(C)N1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.54
ALDH1A1 P00352 5/20 0.54
GAA P10253 4/20 0.54
HPGD P15428 4/20 0.54
GLA P06280 3/20 0.54
CASP1 P29466 1/20 0.54
CASP7 P55210 1/20 0.54
HSD17B10 Q99714 1/20 0.54
MAPT P10636 4/20 0.50
KMT2A Q03164 4/20 0.50
HTT P42858 2/20 0.50
NPC1 O15118 1/20 0.50
NPSR1 Q6W5P4 1/20 0.47
ADORA3 P0DMS8 2/20 0.44
CACNA1F O60840 2/20 0.44
CACNA1D Q01668 2/20 0.44
CACNA1S Q13698 2/20 0.44
CACNA1C Q13936 2/20 0.44
NR1I2 O75469 1/20 0.42
NR3C1 P04150 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9434601 0.83 CACNA1F (0.52) KDM4EALDH1A1MAPTKMT2AADORA3
SCHEMBL9433980 0.83 CACNA1F (0.52) MAPTKMT2AADORA3CACNA1FCACNA1D
SCHEMBL9434657 0.82 CACNA1F (0.51) MAPTKMT2AADORA3CACNA1FCACNA1D
SCHEMBL9434138 0.81 MAPT (0.46) KDM4EALDH1A1GAAHPGDGLA
SCHEMBL9434369 0.81 MAPT (0.63) MAPTKMT2AADORA3CACNA1FCACNA1D
SCHEMBL9434484 0.81 LMNA (0.55) ALDH1A1MAPTKMT2AHTTADORA3
SCHEMBL9434367 0.80 CACNA1F (0.44) MAPTKMT2AADORA3CACNA1FCACNA1D
SCHEMBL9433965 0.80 CACNA1F (0.58) MAPTKMT2AADORA3CACNA1FCACNA1D
SCHEMBL9433883 0.79 CACNA1F (0.71) MAPTKMT2AADORA3CACNA1FCACNA1D
SCHEMBL9434781 0.79 MEN1 (0.63) KDM4EALDH1A1GAAHPGDGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5276150-A Vasodilators, anticoagulants, calcium channel blockers FUJIREBIO INC. (JP) 1994-01-04 US disclosed
EP-0400660-A1 1,4-dihydropyridine derivatives FUJIREBIO INC. (JP) 1990-12-05 EP disclosed